We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Life Technologies and DaAn Gene Form Joint Diagnostic Business

By LabMedica International staff writers
Posted on 30 Jan 2012
Life Technologies (Carlsbad, CA, USA) has signed an agreement with DaAn Gene (Guangzhou, China), a leading company in molecular in vitro diagnostics (IVD), to form Life Technologies DaAn Diagnostics (Guangzhou, China), a joint venture diagnostics business. More...
Financial terms of the deal were not disclosed.

Life Technologies DaAn Diagnostics will develop and commercialize a portfolio of molecular diagnostic assays using Life Technologies' 3500Dx capillary electrophoresis instrument and the Big Dye Cycle Sequencing technologies, focused on IVD assays for oncology, infectious, and genetic diseases. The joint venture allows both companies to expand the use of capillary electrophoresis technology into the Chinese clinical diagnostics market.

The 3500Dx instrument is a capillary-based Sanger Sequencer intended for use in the analysis of human DNA for the detection of genetic changes that indicate disease presence or improved response to various therapies. The genetic analyzer was approved by China's State Food and Drug Administration (SFDA) for IVD diagnostic use in China in October 2011.

"The joint venture will help us offer leading medical diagnostic technologies with cost-effective solutions to Chinese healthcare professionals," said Dr. Siddhartha Kadia, president of Life Technologies, Greater China. "This approach leverages our expertise in platform development and DaAn's expertise in regulated markets with kit development and commercialization."

DaAn Gene Co., Ltd. of Sun Yat-sen University (Guangzhou, China) is a biotech enterprise focused on molecular diagnostic techniques. With the Certificate of Good manufacturing practice (GMP), DAAN Gene is committed to R&D, production, and service of in vitro diagnostic products.

Life Technologies is a global biotechnology company whose systems, consumables, and services enable scientists to accelerate scientific and medical advancements to improve human health. The company manufactures both molecular diagnostic and research use only products.

Related Links:
Life Technologies
DaAn Gene
Sun Yat-sen University


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.